🧠 Alzheimer's clinical trials w/ DNA sequencing
In 2017, I founded a company called Ikigai. The idea was to sequence a person’s DNA & RNA and match them with the best clinical trial for Alzheimer’s disease. With enough sequencing data, we would develop a drug that would cure Alzheimer’s. After 2 years of working on it, the company failed and it was one of the most painful experiences of my life. If you’ve ever been a startup founder that worked relentlessly on a startup with nearly 0 traction, you’ll know the pain....